Yuyu Pharma, Inc. (KRX: 000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,440.00
-70.00 (-1.55%)
Dec 20, 2024, 3:30 PM KST

Yuyu Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
71,85185,445102,750130,082108,19966,725
Upgrade
Market Cap Growth
1.63%-16.84%-21.01%20.22%62.16%8.45%
Upgrade
Enterprise Value
75,809119,950114,352120,293117,74869,419
Upgrade
Last Close Price
4440.005280.006096.317528.516941.925316.54
Upgrade
PE Ratio
8.40---108.3515.04
Upgrade
PS Ratio
0.530.620.741.121.100.73
Upgrade
PB Ratio
0.600.710.831.010.920.74
Upgrade
P/TBV Ratio
0.640.810.931.110.990.78
Upgrade
P/FCF Ratio
2.99----13.01
Upgrade
P/OCF Ratio
2.59203.02-28.85-5.06
Upgrade
EV/Sales Ratio
0.560.870.821.041.200.76
Upgrade
EV/EBITDA Ratio
4.2724.6925.7821.0911.586.20
Upgrade
EV/EBIT Ratio
6.26--100.2318.788.60
Upgrade
EV/FCF Ratio
3.16----13.53
Upgrade
Debt / Equity Ratio
0.270.330.320.300.170.30
Upgrade
Debt / EBITDA Ratio
1.958.118.866.871.962.41
Upgrade
Debt / FCF Ratio
1.48----5.25
Upgrade
Asset Turnover
0.680.700.720.660.670.67
Upgrade
Inventory Turnover
1.962.112.642.892.602.72
Upgrade
Quick Ratio
1.021.140.862.432.201.11
Upgrade
Current Ratio
1.702.031.503.293.501.53
Upgrade
Return on Equity (ROE)
8.21%-4.55%-3.51%-0.75%2.32%6.27%
Upgrade
Return on Assets (ROA)
3.96%-0.24%-0.19%0.43%2.68%3.70%
Upgrade
Return on Capital (ROIC)
4.76%-0.29%-0.22%0.49%3.08%4.30%
Upgrade
Earnings Yield
11.91%-8.40%-5.83%-1.70%1.19%7.08%
Upgrade
FCF Yield
33.41%-4.79%-11.20%-1.20%-13.60%7.69%
Upgrade
Payout Ratio
0.00%---118.38%30.58%
Upgrade
Buyback Yield / Dilution
-25.44%1.89%-3.90%-32.81%19.87%-0.14%
Upgrade
Total Shareholder Return
-25.44%1.89%-3.90%-32.81%19.87%-0.14%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.